Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases

被引:92
作者
Rezza, G
Andreoni, M
Dorrucci, M
Pezzotti, P
Monini, P
Zerboni, R
Salassa, B
Colangeli, V
Sarmati, L
Nicastri, E
Barbanera, M
Pristerà, R
Aiuti, F
Ortona, L
Ensoli, B
机构
[1] Ist Super Sanita, Ctr Operat AIDS, Epidemiol & Biostat Lab, I-00161 Rome, Italy
[2] Ist Super Sanita, Virol Lab, I-00161 Rome, Italy
[3] Univ Roma Tor Vergata, Dept Infect Dis, Rome, Italy
[4] Univ Milan, Sexually Transmitted Dis Clin, I-20122 Milan, Italy
[5] Osped Amedeo di Savoia, Div Infect Dis, Turin, Italy
[6] Univ Bologna, Infect Dis Clin, I-40126 Bologna, Italy
[7] Osped Riuniti Bergamo, Div Infect Dis, Livorno, Italy
[8] Osped Reg, Div Infect Dis, Bolzano, Italy
[9] Univ Roma La Sapienza, Rome, Italy
[10] Univ Cattolica Sacro Cuore, I-00168 Rome, Italy
关键词
D O I
10.1093/jnci/91.17.1468
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The incidence of Kaposi's sarcoma (KS) is increased severalfold in individuals infected with human immunodeficiency virus-1 (HIV). Human herpesvirus 8 (HHVS) has also been implicated in KS. We investigated several factors that may determine the onset of KS, particularly HHVS infection in individuals after becoming seropositive for HIV. Methods: We studied 366 individuals belonging to different HIV-exposure categories (i.e., homosexual activity, intravenous drug use, and heterosexual contact) for whom a negative HIV serologic test and then a positive HIV serologic test were available within a 2-year period. HHV8 antibody testing was performed by use of an immunofluorescence assay on the first serum sample available after the first positive HIV test. Actuarial rates of progression of KS and of other acquired immunodeficiency syndrome (AIDS)-defining diseases were estimated by use of time-to-event statistical methods. All statistical tests were two-sided. Results: Twenty-one of the 366 study participants developed AIDS-related KS, and 83 developed AIDS without KS. One hundred forty (38.3%) participants had detectable anti-HHV8 antibodies. The actuarial progression rate to KS among persons co-infected with HIV/HHV8 was nearly 30% by 10 years after HIV seroconversion. Increasing HHV8 antibody titers increased the risk of developing KS (for seronegative versus highest titer [1 :125 serum dilution], adjusted relative hazard [RH] = 51.82; 95% confidence interval [CI] = 6.08-441.33) but not of other AIDS-defining diseases (adjusted RH = 1.14; 95% CI = 0.72-1.80). HHV8-seropositive homosexual men compared with HHV8-seropositive participants from other HIV-exposure categories showed an increased risk of KS that approached statistical significance (adjusted RH = 6.93; 95% CI = 0.88-54.84). Conclusions: Approximately one third of individuals coinfected with HIV/HHV8 developed KS within 10 years after HIV seroconversion. Progression to KS increased with time after HIV seroconversion, Higher antibody titers to HHV8 appear to be related to faster progression to KS but not to other AIDS-defining diseases.
引用
收藏
页码:1468 / 1474
页数:7
相关论文
共 44 条
[1]   HERPES-LIKE SEQUENCES IN HIV-INFECTED AND UNINFECTED KAPOSIS-SARCOMA PATIENTS [J].
AMBROZIAK, JA ;
BLACKBOURN, DJ ;
HERNDIER, BG ;
GLOGAU, RG ;
GULLETT, JH ;
MCDONALD, AR ;
LENNETTE, ET ;
LEVY, JA .
SCIENCE, 1995, 268 (5210) :582-583
[2]   EXPANDED EUROPEAN AIDS CASE DEFINITION [J].
ANCELLEPARK, R .
LANCET, 1993, 341 (8842) :441-441
[3]   High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: Evidence of nonsexual transmission [J].
Andreoni, M ;
El-Sawaf, G ;
Rezza, G ;
Ensoli, B ;
Nicastri, E ;
Ventura, L ;
Ercoli, L ;
Sarmati, L ;
Rocchi, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (05) :465-469
[4]   KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-RELATED BODY-CAVITY-BASED LYMPHOMAS [J].
CESARMAN, E ;
CHANG, Y ;
MOORE, PS ;
SAID, JW ;
KNOWLES, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (18) :1186-1191
[5]   IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
CHANG, Y ;
CESARMAN, E ;
PESSIN, MS ;
LEE, F ;
CULPEPPER, J ;
KNOWLES, DM ;
MOORE, PS .
SCIENCE, 1994, 266 (5192) :1865-1869
[6]   Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma [J].
Chuck, S ;
Grant, RM ;
KatongoleMbidde, E ;
Conant, M ;
Ganem, D .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) :248-251
[7]   CAN ANTIVIRAL AGENTS DECREASE THE OCCURRENCE OF KAPOSIS-SARCOMA [J].
COSTAGLIOLA, D ;
MARYKRAUSE, M .
LANCET, 1995, 346 (8974) :578-578
[8]  
Council of State and Territorial Epidemiologists, 1987, MMWR MORB MORTAL S1, V36, p1S
[9]   Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia [J].
Gaidano, G ;
Pastore, C ;
Gloghini, A ;
Cusini, M ;
Nomdedeu, J ;
Volpe, G ;
Capello, D ;
Vaccher, E ;
Bordes, R ;
Tirelli, U ;
Saglio, G ;
Carbone, A .
AIDS, 1996, 10 (09) :941-949
[10]   RISK-FACTORS FOR KAPOSIS-SARCOMA IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE [J].
GALLANT, JE ;
MOORE, RD ;
RICHMAN, DD ;
KERULY, J ;
CHAISSON, RE ;
BARTLETT, J ;
MCAVINUE, S ;
BRYSON, Y ;
COHEN, H ;
FISCHL, M ;
BOLIN, T ;
BURROUGH, Y ;
MILDVAN, D ;
FOX, A ;
RICHMAN, D ;
FREEMAN, B ;
SIMON, G ;
GRABOWY, KW ;
CHERNOFF, D ;
DUFF, P ;
THOMPSON, S ;
BARRETT, K ;
AWE, R ;
LEONARD, S ;
TURNER, P ;
HAWKINS, M ;
MURRAY, H ;
BOWERS, J ;
TILSON, H ;
SMILEY, L .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (05) :566-572